Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice
Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exist...
Gespeichert in:
Veröffentlicht in: | Atherosclerosis 2017-11, Vol.266, p.182-189 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 189 |
---|---|
container_issue | |
container_start_page | 182 |
container_title | Atherosclerosis |
container_volume | 266 |
creator | Zhao, Liyang Cozzo, Alyssa J. Johnson, Amy R. Christensen, Taylor Freemerman, Alex J. Bear, James E. Rotty, Jeremy D. Bennett, Brian J. Makowski, Liza |
description | Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exists. We previously demonstrated that MΦ fatty acid transport protein 1 (FATP1, Slc27a1) was necessary to maintain the oxidative and anti-inflammatory AAM phenotype in vivo in a model of diet-induced obesity. The aim of this study was to examine how MΦ metabolic reprogramming through FATP1 ablation affects the process of atherogenesis. We hypothesized that FATP1 limits MΦ-mediated inflammation during atherogenesis. Thus, mice lacking MΦ Fatp1 would display elevated formation of atherosclerotic lesions in a mouse model lacking the low-density lipoprotein (LDL) receptor (Ldlr−/−).
We transplanted bone marrow collected from Fatp1+/+ or Fatp1−/− mice into Ldlr−/− mice and fed chimeric mice a Western diet for 12 weeks. Body weight, blood glucose, and plasma lipids were measured. Aortic sinus and aorta lesions were quantified. Atherosclerotic plaque composition, oxidative stress, and inflammation were analyzed histologically.
Compared to Fatp1+/+Ldlr−/− mice, Fatp1−/−Ldlr−/− mice exhibited significantly larger lesion area and elevated oxidative stress and inflammation in the atherosclerotic plaque. Macrophage and smooth muscle cell content did not differ by Fatp1 genotype. There were no significant systemic alterations in LDL, high-density lipoprotein (HDL), total cholesterol, or triacylglyceride, suggesting that the effect was local to the cells of the vessel microenvironment in a Fatp1-dependent manner.
MΦ Fatp1 limits atherogenesis and may be a viable target to metabolically reprogram MΦs.
•Lack of Fatp1 led to increased atherosclerotic lesions in Ldlr−/− mice.•Larger lesions in Fatp1−/−Ldlr−/− mice were not due to systemic changes in lipids.•Lesions in Fatp1−/−Ldlr−/− mice had greater oxidative stress and inflammation. |
doi_str_mv | 10.1016/j.atherosclerosis.2017.10.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5705203</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0021915017313291</els_id><sourcerecordid>1952101099</sourcerecordid><originalsourceid>FETCH-LOGICAL-c499t-1370780b01422d67e6a8d725456ea1bfc5edd4c491ef4a95b0402340a5bc69233</originalsourceid><addsrcrecordid>eNqNkcFu1DAURS0EokPLLyBvkNhk-uzYcbwACVVtQRqpG7q2HPuFekjiwc5UKl_Aup_Il-BoSlVYsbC9uOfdZ91LyFsGawasOd2u7XyDKWY3LHfIaw5MFW0NoJ-RFWuVrphoxXOyAuCs0kzCEXmV8xYAhGLtS3LENdRStWxFrjbWfaOxp-MdDjF4emHnHaNhcgltxkyfbpuDowPmECeaww8sFN34If36eX9aDh2DwxPyordDxtcP7zG5vjj_cvap2lxdfj77uKmc0HquWK1AtdABE5z7RmFjW6-4FLJBy7reSfReFJZhL6yWHQjgtQArO9doXtfH5MPBd7fvRvQOpznZwexSGG26M9EG87cyhRvzNd4aqUByWAzePRik-H2PeTZjyA6HwU4Y99kwLXkJHLQu6PsD6koQOWH_uIaBWUoxW_NPKWYpZZFLKWX-zdO_Pk7_aaEAlwcAS2K3AZPJLuDk0IeEbjY-hv9c9Rv6dqpC</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1952101099</pqid></control><display><type>article</type><title>Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Zhao, Liyang ; Cozzo, Alyssa J. ; Johnson, Amy R. ; Christensen, Taylor ; Freemerman, Alex J. ; Bear, James E. ; Rotty, Jeremy D. ; Bennett, Brian J. ; Makowski, Liza</creator><creatorcontrib>Zhao, Liyang ; Cozzo, Alyssa J. ; Johnson, Amy R. ; Christensen, Taylor ; Freemerman, Alex J. ; Bear, James E. ; Rotty, Jeremy D. ; Bennett, Brian J. ; Makowski, Liza</creatorcontrib><description>Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exists. We previously demonstrated that MΦ fatty acid transport protein 1 (FATP1, Slc27a1) was necessary to maintain the oxidative and anti-inflammatory AAM phenotype in vivo in a model of diet-induced obesity. The aim of this study was to examine how MΦ metabolic reprogramming through FATP1 ablation affects the process of atherogenesis. We hypothesized that FATP1 limits MΦ-mediated inflammation during atherogenesis. Thus, mice lacking MΦ Fatp1 would display elevated formation of atherosclerotic lesions in a mouse model lacking the low-density lipoprotein (LDL) receptor (Ldlr−/−).
We transplanted bone marrow collected from Fatp1+/+ or Fatp1−/− mice into Ldlr−/− mice and fed chimeric mice a Western diet for 12 weeks. Body weight, blood glucose, and plasma lipids were measured. Aortic sinus and aorta lesions were quantified. Atherosclerotic plaque composition, oxidative stress, and inflammation were analyzed histologically.
Compared to Fatp1+/+Ldlr−/− mice, Fatp1−/−Ldlr−/− mice exhibited significantly larger lesion area and elevated oxidative stress and inflammation in the atherosclerotic plaque. Macrophage and smooth muscle cell content did not differ by Fatp1 genotype. There were no significant systemic alterations in LDL, high-density lipoprotein (HDL), total cholesterol, or triacylglyceride, suggesting that the effect was local to the cells of the vessel microenvironment in a Fatp1-dependent manner.
MΦ Fatp1 limits atherogenesis and may be a viable target to metabolically reprogram MΦs.
•Lack of Fatp1 led to increased atherosclerotic lesions in Ldlr−/− mice.•Larger lesions in Fatp1−/−Ldlr−/− mice were not due to systemic changes in lipids.•Lesions in Fatp1−/−Ldlr−/− mice had greater oxidative stress and inflammation.</description><identifier>ISSN: 0021-9150</identifier><identifier>EISSN: 1879-1484</identifier><identifier>DOI: 10.1016/j.atherosclerosis.2017.10.009</identifier><identifier>PMID: 29035781</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Animals ; Aorta - metabolism ; Aorta - pathology ; Aortic Diseases - genetics ; Aortic Diseases - metabolism ; Aortic Diseases - pathology ; Atherosclerosis - genetics ; Atherosclerosis - metabolism ; Atherosclerosis - pathology ; Blood Glucose - metabolism ; Bone Marrow Transplantation ; Cells, Cultured ; Cellular Microenvironment ; Disease Models, Animal ; FATP1 ; Fatty acid transport protein ; Fatty Acid Transport Proteins - deficiency ; Fatty Acid Transport Proteins - genetics ; Genetic Predisposition to Disease ; Inflammation - genetics ; Inflammation - metabolism ; Inflammation - pathology ; LDL receptor ; Lipids - blood ; Macrophage ; Macrophage Activation ; Macrophages, Peritoneal - metabolism ; Male ; Metabolic reprogram ; Mice, Knockout ; Oxidative Stress ; Phenotype ; Plaque, Atherosclerotic ; Receptors, LDL - deficiency ; Receptors, LDL - genetics ; Transplantation Chimera</subject><ispartof>Atherosclerosis, 2017-11, Vol.266, p.182-189</ispartof><rights>2017 Elsevier B.V.</rights><rights>Copyright © 2017 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c499t-1370780b01422d67e6a8d725456ea1bfc5edd4c491ef4a95b0402340a5bc69233</citedby><cites>FETCH-LOGICAL-c499t-1370780b01422d67e6a8d725456ea1bfc5edd4c491ef4a95b0402340a5bc69233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0021915017313291$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,776,780,881,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29035781$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhao, Liyang</creatorcontrib><creatorcontrib>Cozzo, Alyssa J.</creatorcontrib><creatorcontrib>Johnson, Amy R.</creatorcontrib><creatorcontrib>Christensen, Taylor</creatorcontrib><creatorcontrib>Freemerman, Alex J.</creatorcontrib><creatorcontrib>Bear, James E.</creatorcontrib><creatorcontrib>Rotty, Jeremy D.</creatorcontrib><creatorcontrib>Bennett, Brian J.</creatorcontrib><creatorcontrib>Makowski, Liza</creatorcontrib><title>Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice</title><title>Atherosclerosis</title><addtitle>Atherosclerosis</addtitle><description>Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exists. We previously demonstrated that MΦ fatty acid transport protein 1 (FATP1, Slc27a1) was necessary to maintain the oxidative and anti-inflammatory AAM phenotype in vivo in a model of diet-induced obesity. The aim of this study was to examine how MΦ metabolic reprogramming through FATP1 ablation affects the process of atherogenesis. We hypothesized that FATP1 limits MΦ-mediated inflammation during atherogenesis. Thus, mice lacking MΦ Fatp1 would display elevated formation of atherosclerotic lesions in a mouse model lacking the low-density lipoprotein (LDL) receptor (Ldlr−/−).
We transplanted bone marrow collected from Fatp1+/+ or Fatp1−/− mice into Ldlr−/− mice and fed chimeric mice a Western diet for 12 weeks. Body weight, blood glucose, and plasma lipids were measured. Aortic sinus and aorta lesions were quantified. Atherosclerotic plaque composition, oxidative stress, and inflammation were analyzed histologically.
Compared to Fatp1+/+Ldlr−/− mice, Fatp1−/−Ldlr−/− mice exhibited significantly larger lesion area and elevated oxidative stress and inflammation in the atherosclerotic plaque. Macrophage and smooth muscle cell content did not differ by Fatp1 genotype. There were no significant systemic alterations in LDL, high-density lipoprotein (HDL), total cholesterol, or triacylglyceride, suggesting that the effect was local to the cells of the vessel microenvironment in a Fatp1-dependent manner.
MΦ Fatp1 limits atherogenesis and may be a viable target to metabolically reprogram MΦs.
•Lack of Fatp1 led to increased atherosclerotic lesions in Ldlr−/− mice.•Larger lesions in Fatp1−/−Ldlr−/− mice were not due to systemic changes in lipids.•Lesions in Fatp1−/−Ldlr−/− mice had greater oxidative stress and inflammation.</description><subject>Animals</subject><subject>Aorta - metabolism</subject><subject>Aorta - pathology</subject><subject>Aortic Diseases - genetics</subject><subject>Aortic Diseases - metabolism</subject><subject>Aortic Diseases - pathology</subject><subject>Atherosclerosis - genetics</subject><subject>Atherosclerosis - metabolism</subject><subject>Atherosclerosis - pathology</subject><subject>Blood Glucose - metabolism</subject><subject>Bone Marrow Transplantation</subject><subject>Cells, Cultured</subject><subject>Cellular Microenvironment</subject><subject>Disease Models, Animal</subject><subject>FATP1</subject><subject>Fatty acid transport protein</subject><subject>Fatty Acid Transport Proteins - deficiency</subject><subject>Fatty Acid Transport Proteins - genetics</subject><subject>Genetic Predisposition to Disease</subject><subject>Inflammation - genetics</subject><subject>Inflammation - metabolism</subject><subject>Inflammation - pathology</subject><subject>LDL receptor</subject><subject>Lipids - blood</subject><subject>Macrophage</subject><subject>Macrophage Activation</subject><subject>Macrophages, Peritoneal - metabolism</subject><subject>Male</subject><subject>Metabolic reprogram</subject><subject>Mice, Knockout</subject><subject>Oxidative Stress</subject><subject>Phenotype</subject><subject>Plaque, Atherosclerotic</subject><subject>Receptors, LDL - deficiency</subject><subject>Receptors, LDL - genetics</subject><subject>Transplantation Chimera</subject><issn>0021-9150</issn><issn>1879-1484</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkcFu1DAURS0EokPLLyBvkNhk-uzYcbwACVVtQRqpG7q2HPuFekjiwc5UKl_Aup_Il-BoSlVYsbC9uOfdZ91LyFsGawasOd2u7XyDKWY3LHfIaw5MFW0NoJ-RFWuVrphoxXOyAuCs0kzCEXmV8xYAhGLtS3LENdRStWxFrjbWfaOxp-MdDjF4emHnHaNhcgltxkyfbpuDowPmECeaww8sFN34If36eX9aDh2DwxPyordDxtcP7zG5vjj_cvap2lxdfj77uKmc0HquWK1AtdABE5z7RmFjW6-4FLJBy7reSfReFJZhL6yWHQjgtQArO9doXtfH5MPBd7fvRvQOpznZwexSGG26M9EG87cyhRvzNd4aqUByWAzePRik-H2PeTZjyA6HwU4Y99kwLXkJHLQu6PsD6koQOWH_uIaBWUoxW_NPKWYpZZFLKWX-zdO_Pk7_aaEAlwcAS2K3AZPJLuDk0IeEbjY-hv9c9Rv6dqpC</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Zhao, Liyang</creator><creator>Cozzo, Alyssa J.</creator><creator>Johnson, Amy R.</creator><creator>Christensen, Taylor</creator><creator>Freemerman, Alex J.</creator><creator>Bear, James E.</creator><creator>Rotty, Jeremy D.</creator><creator>Bennett, Brian J.</creator><creator>Makowski, Liza</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171101</creationdate><title>Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice</title><author>Zhao, Liyang ; Cozzo, Alyssa J. ; Johnson, Amy R. ; Christensen, Taylor ; Freemerman, Alex J. ; Bear, James E. ; Rotty, Jeremy D. ; Bennett, Brian J. ; Makowski, Liza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c499t-1370780b01422d67e6a8d725456ea1bfc5edd4c491ef4a95b0402340a5bc69233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>Aorta - metabolism</topic><topic>Aorta - pathology</topic><topic>Aortic Diseases - genetics</topic><topic>Aortic Diseases - metabolism</topic><topic>Aortic Diseases - pathology</topic><topic>Atherosclerosis - genetics</topic><topic>Atherosclerosis - metabolism</topic><topic>Atherosclerosis - pathology</topic><topic>Blood Glucose - metabolism</topic><topic>Bone Marrow Transplantation</topic><topic>Cells, Cultured</topic><topic>Cellular Microenvironment</topic><topic>Disease Models, Animal</topic><topic>FATP1</topic><topic>Fatty acid transport protein</topic><topic>Fatty Acid Transport Proteins - deficiency</topic><topic>Fatty Acid Transport Proteins - genetics</topic><topic>Genetic Predisposition to Disease</topic><topic>Inflammation - genetics</topic><topic>Inflammation - metabolism</topic><topic>Inflammation - pathology</topic><topic>LDL receptor</topic><topic>Lipids - blood</topic><topic>Macrophage</topic><topic>Macrophage Activation</topic><topic>Macrophages, Peritoneal - metabolism</topic><topic>Male</topic><topic>Metabolic reprogram</topic><topic>Mice, Knockout</topic><topic>Oxidative Stress</topic><topic>Phenotype</topic><topic>Plaque, Atherosclerotic</topic><topic>Receptors, LDL - deficiency</topic><topic>Receptors, LDL - genetics</topic><topic>Transplantation Chimera</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhao, Liyang</creatorcontrib><creatorcontrib>Cozzo, Alyssa J.</creatorcontrib><creatorcontrib>Johnson, Amy R.</creatorcontrib><creatorcontrib>Christensen, Taylor</creatorcontrib><creatorcontrib>Freemerman, Alex J.</creatorcontrib><creatorcontrib>Bear, James E.</creatorcontrib><creatorcontrib>Rotty, Jeremy D.</creatorcontrib><creatorcontrib>Bennett, Brian J.</creatorcontrib><creatorcontrib>Makowski, Liza</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Atherosclerosis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhao, Liyang</au><au>Cozzo, Alyssa J.</au><au>Johnson, Amy R.</au><au>Christensen, Taylor</au><au>Freemerman, Alex J.</au><au>Bear, James E.</au><au>Rotty, Jeremy D.</au><au>Bennett, Brian J.</au><au>Makowski, Liza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice</atitle><jtitle>Atherosclerosis</jtitle><addtitle>Atherosclerosis</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>266</volume><spage>182</spage><epage>189</epage><pages>182-189</pages><issn>0021-9150</issn><eissn>1879-1484</eissn><abstract>Altered metabolism is an important regulator of macrophage (MΦ) phenotype, which contributes to inflammatory diseases such as atherosclerosis. Broadly, pro-inflammatory, classically-activated MΦs (CAM) are glycolytic while alternatively-activated MΦs (AAM) oxidize fatty acids, although overlap exists. We previously demonstrated that MΦ fatty acid transport protein 1 (FATP1, Slc27a1) was necessary to maintain the oxidative and anti-inflammatory AAM phenotype in vivo in a model of diet-induced obesity. The aim of this study was to examine how MΦ metabolic reprogramming through FATP1 ablation affects the process of atherogenesis. We hypothesized that FATP1 limits MΦ-mediated inflammation during atherogenesis. Thus, mice lacking MΦ Fatp1 would display elevated formation of atherosclerotic lesions in a mouse model lacking the low-density lipoprotein (LDL) receptor (Ldlr−/−).
We transplanted bone marrow collected from Fatp1+/+ or Fatp1−/− mice into Ldlr−/− mice and fed chimeric mice a Western diet for 12 weeks. Body weight, blood glucose, and plasma lipids were measured. Aortic sinus and aorta lesions were quantified. Atherosclerotic plaque composition, oxidative stress, and inflammation were analyzed histologically.
Compared to Fatp1+/+Ldlr−/− mice, Fatp1−/−Ldlr−/− mice exhibited significantly larger lesion area and elevated oxidative stress and inflammation in the atherosclerotic plaque. Macrophage and smooth muscle cell content did not differ by Fatp1 genotype. There were no significant systemic alterations in LDL, high-density lipoprotein (HDL), total cholesterol, or triacylglyceride, suggesting that the effect was local to the cells of the vessel microenvironment in a Fatp1-dependent manner.
MΦ Fatp1 limits atherogenesis and may be a viable target to metabolically reprogram MΦs.
•Lack of Fatp1 led to increased atherosclerotic lesions in Ldlr−/− mice.•Larger lesions in Fatp1−/−Ldlr−/− mice were not due to systemic changes in lipids.•Lesions in Fatp1−/−Ldlr−/− mice had greater oxidative stress and inflammation.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>29035781</pmid><doi>10.1016/j.atherosclerosis.2017.10.009</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-9150 |
ispartof | Atherosclerosis, 2017-11, Vol.266, p.182-189 |
issn | 0021-9150 1879-1484 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5705203 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Animals Aorta - metabolism Aorta - pathology Aortic Diseases - genetics Aortic Diseases - metabolism Aortic Diseases - pathology Atherosclerosis - genetics Atherosclerosis - metabolism Atherosclerosis - pathology Blood Glucose - metabolism Bone Marrow Transplantation Cells, Cultured Cellular Microenvironment Disease Models, Animal FATP1 Fatty acid transport protein Fatty Acid Transport Proteins - deficiency Fatty Acid Transport Proteins - genetics Genetic Predisposition to Disease Inflammation - genetics Inflammation - metabolism Inflammation - pathology LDL receptor Lipids - blood Macrophage Macrophage Activation Macrophages, Peritoneal - metabolism Male Metabolic reprogram Mice, Knockout Oxidative Stress Phenotype Plaque, Atherosclerotic Receptors, LDL - deficiency Receptors, LDL - genetics Transplantation Chimera |
title | Lack of myeloid Fatp1 increases atherosclerotic lesion size in Ldlr−/− mice |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T10%3A37%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lack%20of%20myeloid%20Fatp1%20increases%20atherosclerotic%20lesion%20size%20in%20Ldlr%E2%88%92/%E2%88%92%20mice&rft.jtitle=Atherosclerosis&rft.au=Zhao,%20Liyang&rft.date=2017-11-01&rft.volume=266&rft.spage=182&rft.epage=189&rft.pages=182-189&rft.issn=0021-9150&rft.eissn=1879-1484&rft_id=info:doi/10.1016/j.atherosclerosis.2017.10.009&rft_dat=%3Cproquest_pubme%3E1952101099%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1952101099&rft_id=info:pmid/29035781&rft_els_id=S0021915017313291&rfr_iscdi=true |